Holly Schachner

Dr. Schachner joined Myokardia in September 2020. She has extensive experience in medical affairs and late stage clinical development across a range of therapeutic and device areas. Holly has driven transformative changes to create strategic global medical teams that have launched new therapies and developed innovative approaches for clinical endpoint and outcome studies. Her teams have won prestigious awards from the Academy of Interactive & Visual Arts for their innovation and impact.

Most recently, Holly was Chief Medical Officer, Global Specialty Medicine at Allergan, where she led the transformation to a matrixed medical organization across multiple therapeutic areas in phase 1 through phase 4, including CV, GI, Immunology, Women’s Health and Anti-Infectives. Holly also served as Co-Head of Medical and Safety COVID-19 Task Force at Allergan, leading a cross functional team to create and implement governance measures across the global business.

Prior to Allergan, Holly was at Sanofi, where she was the North America Medical Head for the Diabetes Cardiovascular Business Unit and served as U.S. Medical Chair across all business units. As the NA medical head, she led launch preparedness for several pipeline products. As the US Medical Chair, Holly met with stakeholders on Capitol Hill to gather insights on patient and healthcare system needs. Holly served on the Board of Directors of the Sanofi Foundation for North America, which oversaw disaster relief, corporate social responsibility initiatives, and patient assistance programs.

Earlier in her career, Holly held medical leadership positions at Bayer Diabetes Care, Pfizer, Inc., and at Columbia University, where she created and led a highly regarded, multi-disciplinary Pediatric Diabetes team that provided care to patients diagnosed with type 1 diabetes, type 2 diabetes, and obesity.

Holly holds a Doctor of Medicine (MD) degree from the State University of New York, Stony Brook and a Bachelor of Arts in Psychology from the University of Michigan. She completed her Pediatric Residency and Pediatric Endocrinology Fellowship at Mount Sinai Medical Center in New York City. She is a Diplomate of the National Board of Medical Examiners and American Boards of Pediatrics and Pediatric Endocrinology. She previously served on the board of the Juvenile Diabetes Research Foundation New York Chapter.